HAS1 and nonpapillary renal cell carcinoma: Subsequently, we categorized ccRCC patients based on the expression of HAS1 and MMP9, and survival analysis indicated that individuals exhibiting elevated levels of both HAS1 and MMP9 experienced the most unfavorable prognosis (Figure 4I).